Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Curasight A/S reports positive preclinical results with uTREAT[®] in aggressive brain cancer (glioblastoma)
Thursday, June 08, 2023Curasight AS Curasight or the Company TICKER CURAS is pleased to announce preclinical data demonstrating the effectiveness of uTREAT in treating aggressive brain cancer glioblastoma The results from the study validate Curasights strategic focus on d...
Digital Science boosts pharma industry support following OntoChem acquisition
Thursday, June 08, 2023Digital Science is positioning itself to play an even greater role in the pharmaceutical industrys allimportant drug discovery by helping industry sift through a sea of information and focus on the research that matters
Axol Bioscience Collaborates With StrataStem to Deliver Stem Cell Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Thursday, June 08, 2023Axol Bioscience Ltd Axol a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimers Disease AD patient samples Harnessing...
Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval of CARVYKTI® for the Earlier Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Tuesday, June 06, 2023Tianmaiyuanhe Biomedicine Shanghai Co Ltd a clinicalstage biotechnology company announced that it has received approval from the China National Medical Products Administration NMPA The A Drug Clinical Trial The Janssen Pharmaceutical Companies of Joh...
Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
Tuesday, June 06, 2023Fennec Pharmaceuticals Inc NASDAQ FENC TSX FRX a commercial stage specialty pharmaceutical company today announced Pedmarqsi known as PEDMARK in the US was granted marketing authorization by the European Commission Pedmarqsi is the first and only ap...
BioLife Solutions Launches the IntelliRate™ i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer
Tuesday, June 06, 2023BioLife Solutions Inc NASDAQ BLFS BioLife or the Company a leading developer and supplier of classdefining bioproduction products and services for the cell and gene therapy CGT and broader biopharma markets today announced the launch of a new largeca...
OpenBench and Related Sciences Launch Success-Driven Collaboration
Tuesday, June 06, 2023OpenBench Inc a pioneer in successdriven small molecule discovery collaborations today announced the launch of a collaboration with Related Sciences RS a data sciencedriven drug discovery studio to leverage OpenBenchs structurebased machine learning...
Waters and Sartorius Expand Collaboration to Offer Comprehensive Bioanalysis for Downstream Biologics Manufacturing
Monday, June 05, 2023Waters Corporation NYSE WAT and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biological manufacturing expanding their joint agreement started with the analysis of upstream bioprocesses Software...
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial Under Investigation for the Treatment of Rett Syndrome
Monday, June 05, 2023Taysha Gene Therapies Inc Nasdaq TSHA a clinicalstage gene therapy company focused on developing and commercializing AAVbased gene therapies for the treatment of monogenic diseases of the central nervous system CNS today announced that the first pati...
CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics
Monday, June 05, 2023CERo Therapeutics Inc CERo an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms and Phoenix Biotech Acquisition Corp NASDAQPBAX PBAX a special purpose acquisiti...
